Page 2214 - Williams Hematology ( PDFDrive )
P. 2214

2188  Part XII:  Hemostasis and Thrombosis  Chapter 127:  Antibody-mediated Coagulation Factor Deficiencies          2189




                    97.  Rao LV, Zivelin A, Iturbe I, Rapaport SI: Antibody-induced acute factor X deficiency:     104. Lorand L, Maldonado N, Fradera J, et al: Haemorrhagic syndrome of autoimmune ori-
                     Clinical manifestations and properties of the antibody.  Thromb Haemost 72(3):   gin with a specific inhibitor against fibrin stabilizing factor (factor XIII). Br J Haematol
                     363–371, 1994.                                        23(1):17–27, 1972.
                    98.  Goodrick MJ, Prentice AG, Copplestone JA, et al: Acquired factor XI inhibitor in     105. Lorand L, Velasco PT, Murthy SN, et al: Autoimmune antibody in a hemorrhagic patient
                     chronic lymphocytic leukaemia. J Clin Pathol 45(4):352–353, 1992.  interacts with thrombin-activated factor XIII in a unique manner. Blood 93(3):909–917,
                    99.  Ajzner E, Schlammadinger A, Kerenyi A, et al: Severe bleeding complications caused by   1999.
                     an autoantibody against the B subunit of plasma factor XIII: A novel form of acquired     106. Lorand L, Velasco PT, Rinne JR, et al: Autoimmune antibody (IgG Kansas) against the
                     factor XIII deficiency. Blood 113(3):723–725, 2009.   fibrin stabilizing factor (factor XIII) system. Proc Natl Acad Sci U S A 85(1):232–236,
                    100. Daly HM, Carson PJ, Smith JK: Intracerebral haemorrhage due to acquired factor XIII   1988.
                     inhibitor—Successful response to factor XIII concentrate.  Blood Coagul Fibrinolysis     107. Tosetto A, Rodeghiero F, Gatto E, et al: An acquired hemorrhagic disorder of fibrin
                     2(4):507–514, 1991.                                   crosslinking due to IgG antibodies to FXIII, successfully treated with FXIII replacement
                    101. Fukue H, Anderson K, McPhedran P, et al: A unique factor XIII inhibitor to a   and cyclophosphamide. Am J Hematol 48(1):34–39, 1995.
                     fibrin-binding site on factor XIIIA. Blood 79(1):65–74, 1992.    108. James PD, Lillicrap D, Mannucci PM: Alloantibodies in von Willebrand disease. Blood
                    102. Krumdieck R, Shaw DR, Huang ST, et al: Hemorrhagic disorder due to an isoniazid-   122(5):636–640, 2013.
                     associated acquired factor XIII inhibitor in a patient with Waldenstrom’s macroglobu-    109. Federici AB: Acquired von Willebrand syndrome: Is it an extremely rare disorder or do
                     linemia. Am J Med 90(5):639–645, 1991.                we see only the tip of the iceberg? J Thromb Haemost 6(4):565–568, 2008.
                    103. Lopaciuk S, Bykowska K, McDonagh JM, et al: Difference between type I autoimmune
                     inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder. J Clin
                     Invest 61(5):1196–1203, 1978.







































































          Kaushansky_chapter 127_p2183-2190.indd   2189                                                                 17/09/15   3:44 pm
   2209   2210   2211   2212   2213   2214   2215   2216   2217   2218   2219